期刊文献+

基于西格玛度量优化临床检验风险分析质量控制计划 被引量:9

Prioritizing Risk Analysis Quality Control Plan Based on Sigma-Metrics
下载PDF
导出
摘要 六西格玛(6σ)是一种允许对过程性能进行客观评估的技术,可用σ度量量化分析检测过程的性能和风险。EP23A为实验室提供了可选择的多种风险评估技术,以设计个性化的质量控制计划。方法决定图是区分σ性能的工具,使用方法性能数据产生可接受性的直观评估,而操作规范图是基于σ性能确定试验所要求质量控制的直观工具。故障模式和效应分析(FMEA)是风险评估中常用的一种技术,可用于观察医疗实施过程中的关键弱点。合理使用6σ质量控制设计工具能促进FMEA,风险评估过程和QC计划的设计。 Six sigma is a technique that allows objective assessment of process performance. The sigma metric quantifies the performance and the risk of an analytical testing process. EP23A empowers the laboratory to choose among many risk as sessment techniques to design an individualized quality control plan. The method decision chart is a visual tool that differentiates sigma performance,using data on method performance to generate a visual assessment of acceptability. And the operating specifications chart is a visual tool that identifies the quality control (QC) required by a test, based on sigma performance. Failure mode and effects analysis (FMEA) ,a technique commonly used in risk assessment, has been observed to exhibit key weaknesses in health care implementations. The rational use of the six sigma QC design tools can enhance FMEA, the risk assessment process,and design of QC plan.
出处 《现代检验医学杂志》 CAS 2016年第4期154-156,158,共4页 Journal of Modern Laboratory Medicine
关键词 六西格玛 西格玛度量 风险管理 故障模式和效应分析 质量控制计划 six sigma sigma-metrics risk management failure mode and effect analysis quality control plan
  • 相关文献

参考文献3

二级参考文献19

  • 1ISO 31000. Risk management-principles and guidelines[ S]. Interna- tional Organization for Standardization ,2009.
  • 2ISO/IEC Guide 73. Risk management-vocabulary [ S ]. Intenaational Organization for Standardization ,2009.
  • 3CLSI EP23-A. Laboratory quality control based on risk management; approved guideline [ S ]. Clinical and Laboratory Standards Institute, 2011.
  • 4ISO 15198. Clinical laboratory medicine-in vitro diagnostic medical devices-validation of user quality control procedures by the manufac- turer[S]. International Organization for Standardization, 2004.
  • 5Bonini P, Plebani M, Ceriotti F, et al. Errors in laboratory medicine [J]. Clin Chem,2002, 48(5) :691-698.
  • 6ISO 14971. Medical devices-application of risk management to medi- cal devices[S]. International Organization for Standardization,2007.
  • 7ISO/TS 22367. Medical laboratories-reduction of error through risk management and continual improvement [ S ]. International Organiza- tion for Standardization,2008.
  • 8World Health Organization. Report of the fifth work- ing group on the establishment of ischemic heart dis- ease registersEZ. WHO..Copenhagen, 1971.
  • 9Fraser CG. General strategies to set quality specifica tions for reliability performance characteristics [J]. Scandinavian Journal of Clinical and Laboratory In- vestigation, 1999,59 (7) .. 487-490.
  • 10Skitek M. Acceptability limits based on biology goals in haematology EQAS[J]. Accred Qual Assur, 2005, 10(3) : 112-115.

共引文献85

同被引文献86

引证文献9

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部